Intervention of Henagliflozin on Liver Fibrosis in Patients with Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) and Type 2 Diabetes Mellitus (T2DM)
Latest Information Update: 14 Jan 2025
Price :
$35 *
At a glance
- Drugs Henagliflozin (Primary) ; Metformin
- Indications Hepatic fibrosis
- Focus Therapeutic Use
- 14 Jan 2025 New trial record